维百奥(北京)生物科技有限公司

400-001-2615
info@vicbio.com
产品名称 Human VEGFR2 / KDR / CD309 Antibody (AT001, Research Use)
目录号 NBR-0938
别名 CD309; FLK1; VEGFR; VEGFR2
外观 Transparent Liquid
分子量 150kDa
CAS N/A
溶解度 Water, PBS, TBS Buffer,etc.
存储条件 Temp. -80℃
保存时间 see COA
备注1 CHO Expressed
备注2 Ab. Isotype - IgG
目录号 规格 价格 库存状态  
NBR-0938-100UG 100ug ¥550 请咨询
NBR-0938-1MG 1mg ¥3500 请咨询
NBR-0938-5MG 5mg ¥7500 请咨询



【产品概况】
产品名称:Human VEGFR2 / KDR / CD309 Antibody (AT001, Research Use)
产品编号:NBR-0938
针对靶点:VEGFR2 / KDR / CD309
抗体药商品名:AT001
抗体药描述:AT-001 is an investigational, novel Aldose Reductase Inhibitor (ARI) being developed as an oral therapy for the treatment of Diabetic Cardiomyopathy (DbCM). AT-001 is currently being studied in a Phase 3 registrational study in DbCM.

【产品参数】
产品外观:Transparent Liquid
分子量:~150kDa
CAS:N/A
溶解度:Water; PBS, TBS Buffer等
表达系统:CHO Expressed
抗体亚型:Ab. Isotype - IgG

 
【基因信息】
Gene Name: KDR
Synonyms: CD309; FLK1; VEGFR; VEGFR2
Target Description: Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis. 
Ensembl: ENSG00000128052
Uniprot: P35968 
 
相关产品